ISSN (Print):
1871-529X
ISSN (Online):
2212-4063
Download PDF Flyer

Cardiovascular & Hematological Disorders-Drug Targets

(Formerly as Current Drug Targets - Cardiovascular & Hematological Disorders) Limited Time Complementary OA Offer Papers submitted on or before March 31, 2024, will be published as Promotional Open Access

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics... View all

Volume 24 , Issues 4, 2024

Back Journal Home

Institutional Members
Topic(s) Covered

3 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

COPE Compliant
Archived in
Endorsement(s)
"The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."

Garry X. Shen
Univ. of Manitoba, Canada
© 2024 Bentham Science Publishers | Privacy Policy